-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Co-Diagnostics, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2023.
- Co-Diagnostics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was -$2.21M, a 62.9% decline year-over-year.
- Co-Diagnostics, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$2.42M, a 49.7% increase from 2022.
- Co-Diagnostics, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$4.81M, a 617% decline from 2021.
- Co-Diagnostics, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $930K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)